MedTrace Logo

Investigation of Hypophosphataemia Following Intravenous Iron

NCT04502784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-08-06

No results posted yet for this study

Summary

Anaemia (low haemoglobin levels) can develop in a number of conditions, including chronic kidney disease (CKD) and intestinal conditions (e.g. inflammatory bowel disease, intestinal failure). Intravenous iron can be given to patients with these conditions to help correct their aneaemia. However, intravenous iron has been associated with the development of low phosphate levels - hypophophosphataemia. The aim of this study is to determine potential causes of hypophosphataemia following administration of intravenous iron.

Conditions

  • Hypophosphatemia
  • Chronic Kidney Diseases
  • Intestinal Disease
  • Anemia

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    lead OTHER

Principal Investigators

  • Brona Roberts · Beflast Health and Social Care Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04502784 on ClinicalTrials.gov